Cancer: Drug with new approach on impeding DNA repair shows promise in first clinical trial

ScienceDaily
Jun 15, 2020, 6:41 pm138 pts
Berzosertib, an ATR-targeting drug, improves progression-free survival in combination with chemotherapy in patients with high-grade serous ovarian cancer.

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on EcoTopical

Largest turtle nest in the world revealed in drone study 235

Talking Headways Podcast: This Boat is Doing Something Amazing for Transit! 124

A massive eruption 74,000 years ago affected the whole planet: Volcanic glass may show how people survived 114

Utility-Scale Solar Can Withstand Severe Hailstorms. Here’s How 107

Chevy is the fastest-growing EV brand for a reason: These deals are hard to pass up 103

BLUETTI Elite 100 V2 Portable Power Station — CleanTechnica Tested 101

The New Ti7: BYD’s $25,000 Premium SUV PHEV Destroys Remaining Justifications for Pure ICE 98

Wheel-E Podcast: Boost’s flat e-bikes, Dahon IPO, LiveWire sale, more 98

About EcoTopical

Welcome to EcoTopical Your daily eco-friendly green news aggregator.

Leaf through planet Earths environmental headlines in one convenient place. Read, share and discover the latest on ecology, science and green living from the web's most popular sites.